Get the app!
Back to Trades

Deardorf Caren

DirectorCIK 0001871152

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
2
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

Across 2 filings between 2026, Deardorf Caren, Director, has disclosed $4.6M in transactions — all concentrated in Crinetics Pharmaceuticals, Inc. (CRNX). Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
Sep 1CRNX
Crinetics Pharmaceuticals, Inc.
Deardorf CarenDirectorDisposed$4.2M
Jun 22CRNX
Crinetics Pharmaceuticals, Inc.
Deardorf CarenDirectorGrant$349.0K

2 filings